Data Characteristics
siRNA nucleic acid drug pharmacovigilance data comes from clinical trial reports, real-world evidence (RWE) studies, case reports, medical literature, and regulatory safety updates. This data updates frequently, especially during post-market surveillance, where new adverse event reports are continuous. Document structures are diverse, including structured report forms, unstructured free-text descriptions, and semi-structured medical records. Key fields include patient demographics, medication history, adverse event descriptions, event onset time, severity, outcome, and relevant laboratory test results. Specific areas of focus for this data type are the location of adverse reactions, specific symptom descriptions, and molecular biological indicators related to the siRNA mechanism of action.
Constraints on Vector Models and Indexing
The diverse and frequently updated nature of siRNA nucleic acid drug data requires vector models to quickly process new data and update indexes. This ensures the capture of the latest adverse event signals. Large volumes of unstructured text data, such as patient case descriptions, challenge text segmentation strategies and entity recognition. This necessitates more refined text processing capabilities to accurately extract key information. The unique molecular mechanisms and targets of siRNA mean adverse event descriptions may contain extensive specialized terminology and biomarkers. Vector models require stronger domain knowledge understanding to avoid losing critical biomedical semantics during vectorization. Additionally, some adverse reactions may be delayed or linked to specific genotypes. Index design must support multi-dimensional retrieval and time-series analysis to correlate data across different time points or patient groups.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Chunk Size) | 500-700 characters | Balances semantic completeness and vector computation efficiency. Avoids diluting key information in long texts. |
Chunk overlap (Chunk Overlap) | 50-100 characters | Ensures contextual continuity across chunks. Improves recall of critical information. |
Recall count (Recall Count) | 10-20 items | Provides sufficient contextual information for subsequent processing while maintaining relevance. |
Similarity threshold (Similarity Threshold) | Calibrate based on actual measurements | Adjust based on the precision and recall of actual retrieval results. Typically between 0.7-0.8. |
PARSE_FILE_TIMEOUT_SECONDS | 300-600 seconds | Accommodates parsing large clinical reports or complex structured documents. Prevents timeouts. |
maxContext | 8000-12000 tokens | Ensures enough space for recalled chunks and user queries. Satisfies long-text inference requirements. |
Common Pitfalls
- Key information in some adverse event descriptions is not correctly indexed after uploading documents to the knowledge base, leading to incomplete retrieval results. This occurs when the chunk size is set too long, causing information within a single vector block to be too dispersed, or when the chunking strategy does not adequately consider the characteristics of medical text.
- The system experiences out-of-memory errors or parsing timeouts when processing large volumes of medical literature. This is typically due to
PARSE_FILE_TIMEOUT_SECONDSbeing set too short, which cannot handle complex PDFs or documents containing many tables. - Queries for adverse reactions targeting specific siRNA targets return a large amount of irrelevant information. This indicates that the vector model has insufficient understanding of domain-specific terminology, or the
Similarity threshold(Similarity Threshold) is set too low, leading to the recall of non-precisely matched documents.
Validation Steps
- Upload typical siRNA pharmacovigilance document samples. Check the parsed chunk preview to confirm that key adverse reaction descriptions, dosage information, and onset times remain intact within the chunks.
- For indexed documents, use query statements containing siRNA-specific terminology and adverse reaction symptoms. Check the relevance of the retrieved results to ensure that the recalled document fragments accurately point to the query intent.
- Gradually adjust the
Similarity threshold(Similarity Threshold). Observe changes in the number of recalled items and result quality until a balance is achieved that recalls sufficient relevant information while filtering out clearly irrelevant results. - Monitor system logs for parsing failures, timeouts, or memory warnings during document upload and indexing. Adjust system-level parameters like
PARSE_FILE_TIMEOUT_SECONDSbased on log information.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.